BLUEGRACE ENERGY BOLIVIA
Axiom Life and Health Inc., based in Ottawa, Canada, has unveiled a strategic collaboration with Maximance 2030 LTD and BlueGrace Energy Bolivia (BGEB) to deliver comprehensive health and financing solutions for community development projects.
LONDON, UK / ACCESSWIRE / July 9, 2024 / Julio José Montenegro, CEO of BlueGrace Energy Bolivia (BGEB), and Fernando Ferreira, CEO of Maximance 2030, have indicated that they are very pleased to partner with Axiom in providing essential health services and unlocking new financing opportunities for our development projects.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.This partnership merges Axiom's deep expertise in medical insurance with MAXIMANCE 2030 LTD and BluegGrace Energy Bolivia's skill in public-private partnerships across diverse sectors, including healthcare.
Key Collaboration Highlights:
Innovative Financing: Axiom will leverage carbon credit securities as collateral, empowering Maximance 2030 and BlueGrace Energy Bolivia to obtain capital for community development projects.
Comprehensive Healthcare Solutions: Maximance 2030 and BlueGrace Energy Bolivia will deploy Axiom's robust health insurance plan, Axiom Healthcare, within the communities they serve. This plan offers global access, zero-cost network coverage, and full medical expense coverage, including travel. Axiom will also develop tailored health solutions for each region.
Equitable Profit Sharing: The partners will share the profits from the sale of carbon credit securities equally. Additionally, Axiom will collaborate with sponsors or self-finance premiums to reduce healthcare costs for the beneficiary communities.
"This collaboration combines Axiom's health expertise with the developmental insight of Maximance 2030 and BlueGrace Energy Bolivia, creating a powerful value proposition for communities worldwide," said Amita Kochar, President and Founder of Axiom Life and Health Inc.
As a first step following this announcement and during the inauguration of Expo Favela 2024 at the World Trade Center in São Paulo, Brazil, a meeting was held with the directors of CUFA & 4All (founders and partners of FBank) to discuss the potential development of private "Health Insurance" plans to be implemented with Bluegrace & FBank. These plans would be offered at an affordable price to each new customer who opens a checking account at FBank, leveraging CUFA's strong negotiating power with Brazil's official agencies. The model to be studied would be a public-private partnership (PPP), ensuring quality social insurance for FBank customers.
Mr. Montenegro indicated that this initiative would be a milestone for social actions and a commercial success for FBank, whose motto is that social actions and donations go hand in hand with the profits of companies and donors.
In this regard, Favela Holding and MAG Seguros have launched F Seguros, the first insurance company focused on Brazil's favela communities. This partnership combines Favela Holding's community expertise with MAG's multinational insurance experience. Helder Molina, CEO of MAG, emphasizes the importance of creating insurance tailored to the needs of favela residents. CUFA will be a social partner, training residents to become insurance brokers. F Seguros will offer life insurance, capitalization bonds, and funeral assistance nationwide.
BlueGrace Energy Bolivia is in the early stages of negotiations with F Seguros to join this significant initiative.
BGEB's collaborations are focused on empowering impoverished and indigenous communities around the globe through comprehensive social initiatives and sustainability, guided towards universally accepted principles in human rights, labor, environment, and anti-corruption. By enhancing access to education, healthcare, and infrastructure, BGEB is committed to fostering community development alongside its environmental efforts. This integrated approach, which marries environmental conservation with the transition to clean energy and community empowerment, establishes BGEB as a frontrunner in both ecological preservation and clean energy innovation which underscores the ongoing importance of the partnership as it strives towards a sustainable and carbon-neutral future, serving as a compelling example of what collective action and innovation can accomplish.
As a registered issuer and observer of sustainable financial instruments with the Capital Market Association (ICMA) and recognized by the United Nations Global Compact, BGEB prioritizes authenticity and sustainability, ensuring the integrity of its carbon credits. In that regard, BlueGrace Energy Bolivia, in partnership with MAXIMANCE 2030 LTD, had secured the approval of ISIN UK.BG.MAX 785.985257 which facilitates the support of Forest Conservation Projects through equities, prioritizing due diligence to uphold the integrity of the carbon credits issued by the company.
In recent months, BLUEGRACE ENERGY BOLIVIA has forged agreements with various global companies, including Mbombo Investment Group (MIG), a leading consulting and impact investment firm that manages alternative asset classes, global markets, and a private investments with a network of investors from the US, EU, Israel, Brazil, and African countries, providing them with updated global business information, APRISCO ENERGY INDUSTRIES S.L., a Spain-based company dedicated to a fair and sustainable energy transition; PH Plus, a prominent leader in alkaline water production and distribution in the United States; Healthy Grains S.A., a Guatemalan producer and exporter of nutrient-rich Seeds Like Hemp, Chia, and Flaxseed, and FRIGORIFICOS KOBEFOODS (KFK) a leading Peruvian entity championing the vegan movement in South America. These collaborations are expected to make substantial contributions toward achieving the sustainable development goals set for 2030.
BGEB's journey inspires us all to take action, as together, we can address climate change and protect our planet for future generations.
About BlueGrace Energy Bolivia:
BlueGrace Energy Bolivia (BGEB), a global consortium of experts in diverse areas, is committed to advancing the transition to a net-zero future in response to climate change challenges. Boasting decades of experience, our team is pioneering 21st-century energy transition projects. Grounded in professional expertise and unwavering integrity, we aim to create genuine value for business and society Learn more at:
YouTube: http://tinyurl.com/1BGEB
Instagram: http://tinyurl.com/0BGEB
LinkedIn: http://tinyurl.com/56BGEB
For further information, please contact:
JULIO JOSÉ MONTENEGRO
jmontenegro@bluegracebolivia.com
+1 (305) 972-6173 (Miami - EE.UU.)
NELSON PINEDA MARTINEZ
nelopineda@bluegracebolivia.com
+591 714-72257 (Bolivia)
For all media inquiries, please contact:
Ivan Linde
ivan.linde@bluegracebolivia.com\
+1 (786) 273-7068 (Miami - EE.UU.)
Disclaimer
This announcement is solely for informational use and should not be viewed as financial, legal, or investment guidance. It includes projections and statements that aren't based on past events. Any statement in this release that isn't a historical fact is a projection. Readers should be aware that the basis for these projections might be incorrect and are advised not to rely solely on them. Any projections in this announcement come with a warning. They are current as of the release date, and the Company has no plans to update them, except as mandated by securities regulations.
SOURCE: BlueGrace Energy Bolivia
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release
MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o
GA-ASI and Saab Will Demonstrate AEW&C on MQ-9B in 202617.11.2025 03:05:00 CET | Press release
Two Aerospace Leaders Are Bringing Airborne Early Warning and Control to UAS DUBAI, UAE / ACCESS Newswire / November 16, 2025 / Following their announcement to bring Airborne Early Warning and Control (AEW&C) capability to the world's leading Remotely Piloted Aircraft (RPA) platform, General Atomics Aeronautical Systems, Inc. (GA-ASI) and Saab will now team up to demonstrate the capability in the summer of 2026. The demo will be conducted at GA-ASI's Desert Horizon flight operations facility in Southern California using a GA-ASI MQ-9B equipped with AEW&C supplied by Saab. In partnership with Saab, a leading company in AEW&C systems, GA-ASI is pairing Saab's AEW sensors with the world's longest-range, highest-endurance RPA, the MQ-9B. At sea or over land, adding AEW capabilities on MQ-9B enables persistent air surveillance and enables AEW in areas of the world where it doesn't currently exist or is unaffordable, such as for navy aircraft carriers at sea. "Adding AEW&C to the MQ-9B bring
Doha Tattoo Festival Announced as Ticket Sales Officially Open16.11.2025 12:45:00 CET | Press release
DOHA, QA / ACCESS Newswire / November 16, 2025 / Under the patronage of His Excellency Sheikh Khalifa bin Hamad bin Khalifa Al Thani, Minister of Interior and Commander of the Internal Security Force (Lekhwiya), the first edition of the Doha International Music and Marching Festival (Doha Tattoo) will be held from 16 to 20 December 2025 at Katara Cultural Village. A press conference held at Katara Cultural Village unveiled the line-up of participating bands and ticket details, attended by members of the Doha Tattoo organising committee and partner representatives. The Doha Tattoo will combine precision with musical artistry, showcasing performances by distinguished musical bands from seven countries: the United Kingdom, the United States of America, Turkia, Hashemite Kingdom of Jordan , the Sultanate of Oman, Kazakhstan, and the State of Qatar. The participating line-up includes the Irish Guards and the Royal Air Force Music Services from the United Kingdom, the United States Air Force
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
